Efficacy and safety of finerenone combined with sodium-glucose cotransporter 2 inhibitors in diabetic kidney disease: protocol for a systematic review and meta-analysis.
- DOI
- 10.1136/bmjopen-2025-106220
- Published
- 2025 Nov 12
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-106220,
title = {Efficacy and safety of finerenone combined with sodium-glucose cotransporter 2 inhibitors in diabetic kidney disease: protocol for a systematic review and meta-analysis.},
author = {Wang X and Yu Y and Xiang Y and Liu X and Yu R},
year = {2025},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-106220},
url = {https://doi.org/10.1136/bmjopen-2025-106220}
}RIS
TY - JOUR TI - Efficacy and safety of finerenone combined with sodium-glucose cotransporter 2 inhibitors in diabetic kidney disease: protocol for a systematic review and meta-analysis. AU - Wang X AU - Yu Y AU - Xiang Y AU - Liu X AU - Yu R PY - 2025 JO - BMJ open DO - 10.1136/bmjopen-2025-106220 UR - https://doi.org/10.1136/bmjopen-2025-106220 ER -
APA
X, W., Y, Y., Y, X., X, L., & R, Y. (2025). Efficacy and safety of finerenone combined with sodium-glucose cotransporter 2 inhibitors in diabetic kidney disease: protocol for a systematic review and meta-analysis.. BMJ open. https://doi.org/10.1136/bmjopen-2025-106220
Source records
- pubmed · retrieved 2026-09-25T17:51:51.940Z